Following the initiation of our Phase I clinical study with ALN-TTR01 in July 2010, we hosted a virtual RNAi Roundtable to provide investors with a full overview of our ALN-TTR program.
ALN-TTR RNAi Roundtable webcast, July 2010 (61.9 MB MP3) ALN-TTR RNAi Roundtable, July 2010 (1.0 MB PPT)Monthly Archives For: July 2010
July 12, 2010
Solution-state structure of a fully alternately 2′-F/2′-OMe modified 42-nt dimeric siRNA construct.
July 8, 2010
